Stockscreener 앱 받기
161.42
1.35%
2.15
Insmed Inc 주식(INSM)의 최신 뉴스
Analysts’ Top Healthcare Picks: Insmed (INSM), Roche Holding AG (RHHVF) - The Globe and Mail
EULAV Asset Management Acquires Shares of 90,000 Insmed, Inc. $INSM - MarketBeat
Looking At Insmed's Recent Unusual Options Activity - Benzinga
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - PR Newswire
Nisa Investment Advisors LLC Acquires 8,261 Shares of Insmed, Inc. $INSM - MarketBeat
Aug Reactions: Can Insmed Incorporated expand into new markets2025 Price Action Summary & Short-Term High Return Strategies - baoquankhu1.vn
SG Americas Securities LLC Acquires 13,305 Shares of Insmed, Inc. $INSM - MarketBeat
Bank of America Securities Keeps Their Buy Rating on Insmed (INSM) - The Globe and Mail
Jobs Data: What is the long term forecast for Insmed Incorporated stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Establishment Labs Holdings (ESTA), Sarepta Therapeutics (SRPT) and Insmed (INSM) - The Globe and Mail
Insmed CEO William Lewis sells $3.2 million in shares By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells $3.2 million in shares - Investing.com
Insmed (NASDAQ:INSM) CEO William Lewis Sells 19,215 Shares - MarketBeat
Insmed (BIT:1INSM) Price Target Decreased by 14.88% to 185.76 - Nasdaq
Insmed Insider Sold Shares Worth $351,341, According to a Recent SEC Filing - marketscreener.com
INSMED Chair and CEO William Lewis Sells 19,215 Shares - TradingView — Track All Markets
Short Squeeze: How Insmed Incorporated stock performs after earningsWeekly Risk Summary & Safe Entry Zone Tips - moha.gov.vn
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - MSN
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced - sharewise.com
Insmed Stock Pre-Market (+4.3%): Upbeat Analyst Day Highlights Strong BRINSUPRI™ Uptake & Pipeline - Trefis
MACD Signal: How Insmed Incorporated (IM8N) stock correlates with oil marketsTrade Entry Report & Smart Investment Allocation Insights - Bộ Nội Vụ
Rally Mode: Will Insmed Incorporated stock hit new highs in YEARQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Insmed stock soars as Brinsupri sales beat expectations by 116% - Investing.com Canada
Assessing Insmed (INSM) Valuation After Strong Multi‑Year Returns And Recent Share Price Pullback - simplywall.st
Insmed Incorporated (INSM): Growth Potential In Biotechnology With A 22.62% Upside - DirectorsTalk Interviews
Top Pharmaceutical Stocks To Follow TodayJanuary 11th - MarketBeat
Insmed (INSM) Stock Undervalued by 54.3% Based on DCF Analysis - Intellectia AI
Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? - Yahoo Finance
The Bull Case For Insmed (INSM) Could Change Following Bold 2025 Revenue Guidance HikeLearn Why - Yahoo Finance
What risks investors should watch in Insmed Incorporated stockJuly 2025 Momentum & Low Volatility Stock Suggestions - ulpravda.ru
Tangible book value per share of Insmed Incorporated – BX:IM8N - TradingView — Track All Markets
Jim Cramer on Insmed: "This one is worth keeping an eye on" - MSN
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 - Reuters
Insmed (INSM) Surpasses Revenue Expectations with Strong Growth - GuruFocus
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal - BioPharma Dive
Insmed (NASDAQ:INSM) Shares Gap UpStill a Buy? - MarketBeat
Insmed Maps Aggressive 2026: New Lung Disease Drug, Pipeline AdvancesInsmed (NASDAQ:INSM) - Benzinga
Insmed posts early 2025 revenue beating consensus (INSM:NASDAQ) - Seeking Alpha
Insmed Jumps on ‘Blowout’ Sales Beat for Bronchiectasis Drug Brinsupri - BioSpace
Insmed: Strong Brinsupri Launch, Solid Arikayce Performance, and 2026 Catalysts Underpin Buy Rating - TipRanks
Insmed jumps after forecasting preliminary 2025 revenue above estimates - TradingView — Track All Markets
Insmed Incorporated Provides Revenue Guidance for the Full Year 2025 - marketscreener.com
Insmed shares jump on robust BRINSUPRI rollout and ARIKAYCE outperformance - MSN
Insmed (INSM) Projects Arikayce Revenue of $450M-$470M for FY26 - GuruFocus
Insmed (INSM) Expects Significant Revenue Growth by FY25 - GuruFocus
Insmed (INSM) Plans Multiple Product Launches and Trials Through 2026 - GuruFocus
Insmed stock rises after strong BRINSUPRI launch, ARIKAYCE revenue beat By Investing.com - Investing.com UK
Insmed reports strong Q4 revenue for BRINSUPRI and ARIKAYCE By Investing.com - Investing.com UK
Insmed Inc Provides Business Update at J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
Can Insmed Incorporated stock deliver consistent earnings growth2025 Analyst Calls & Short-Term High Return Ideas - ulpravda.ru
Why Insmed Incorporated (IM8N) stock remains top rated2025 Dividend Review & Precise Swing Trade Alerts - ulpravda.ru
Insmed (NASDAQ:INSM) COO Sells $140,406.14 in Stock - MarketBeat
Insmed (NASDAQ:INSM) CFO Sells $262,941.61 in Stock - MarketBeat
Michael Alexander Smith Sells 1,396 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insider Selling: Insmed (NASDAQ:INSM) Insider Sells 709 Shares of Stock - MarketBeat
William Lewis Sells 4,096 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 3,223 Shares of Stock - MarketBeat
Insmed (NASDAQ:INSM) CFO Sells $293,767.46 in Stock - MarketBeat
Insmed chief legal officer Smith sells $549k in stock By Investing.com - Investing.com Canada
Insmed CFO Bonstein sells $808,733 in stock By Investing.com - Investing.com Nigeria
Insmed chief medical officer Flammer sells $2.8m in stock By Investing.com - Investing.com Canada
0.03%
2.76%
자본화:
|
볼륨(24시간):